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(57) ABSTRACT 
Fluorescent dyes and probes are key components in mul-
tiphoton based fluorescence microscopy imaging of biologi-
cal samples. In order to address the demand for better 
performing dyes for two-photon based imaging, a new series 
of reactive fluorophores tailored for multiphoton imaging 
has been disclosed. These fluorophores are based upon the 
fluorene ring system, known to exhibit high fluorescence 
quantum yields, typically >0.7, and possess high photosta-
bility. They have been functionalized with moieties to act, 
e.g., as efficient amine-reactive fluorescent probes for the 
covalent attachment onto, e.g., proteins and antibodies. The 
synthesis and the single-photon spectral characteristics, as 
well as measured two-photon absorption cross sections of 
the reactive fluorophores in solution are presented. Spectral 
characterizations of bovine serum albumin (BSA) conju-
gated with the new reactive probe is presented. 
9 Claims, 6 Drawing Sheets 
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1 
REACTIVE PROBES FOR TWO-PHOTON 
FLUORESCENT IMAGING AND SENSING 
This invention claims priority based on U.S. Provisional 
Application Ser. No. 60/571,202 filed on May 14, 2004 and 5 
the invention was funded in part by the National Science 
Foundation (ECS-9970078, ECS-0217932, DMR-
9975773), the National Research Council (COBASE), the 
Research Corporation, and the donors of The Petroleum 
Research Fund of the American Chemical Society and the 10 
Florida Hospital Gala Endowed Program for Oncologic 
Research Award. 
2 
cides with increasing usage of two-photon excitation fluo-
rescence imaging applications in the life sciences. 
Previous studies have reported on the design and devel-
opment of fluorene-based organic dyes with very efficient 
two-photon absorption and fluorescence emission properties 
and their use in data storage and sensing applications. 
It would be highly desirable to provide a two-photon 
probe with the properties of high fluorescence quantum 
yields, of high photon absorptivity and high photo stability. 
SUMMARY OF THE INVENTION 
FIELD OF INVENTION 
The primary objective of this invention is to provide a 
two-photon probe with the property of high fluorescence 
15 quantum yields. 
The secondary objective of this invention is to provide a 
two-photon probe with the property of high photon absorp-
tivity. 
This invention relates to two-photon fluorescence imag-
ing, and in particular to a class of fluorescence pro bes having 
the properties of high fluorescence quantum yields, high 
photon absorptivity and high photostability. 
20 
The third objective of this invention is to provide a 
fluorophore probe with the property of high photostability. 
BACKGROUND AND PRIOR ART Novel two-photon probes according to this invention are 
used in a method of multiphon imaging comprising the use 
of reactive fluorophores having a fluorene ring system 
25 wherein said fluorophores are functionalized with moieties 
having the properties of covalent attachment onto proteins, 
antibodies, DNA, and RNA. 
Two-photon laser scanning fluorescence microscopy, first 
demonstrated by Denk et al. in 1990, is based on the 
simultaneous absorption of two low-energy photons by a 
fluorophore in a single quantum event to induce an elec-
tronic excitation that is normally accomplished by a single 
high-energy photon. The main advantage of two-photon 
microscopy over conventional linear microscopy stems from 30 
the high spatial localization of this excitation event due to 
the quadratic relation between the excitation and illumina-
tion intensity. Practically, this means fluorescence occurs 
only at the beam focus and as ultrafast, pulsed, near-IR laser 
irradiation is used as the excitation source, deeper imaging 35 
into optically thick tissue, with restricted photobleaching 
and phototoxicity to the exposed area of the specimen is 
achieved. The tenants of two-photon absorption (2PA) 
enables investigations of complex biological problems and 
experiments on living samples not possible with other 40 
imaging techniques, and highlighted examples of its use in 
the medicinal and biological research areas have been noted. 
Two-photon fluorescence methods and techniques have 
advanced to yield sophisticated imaging techniques, but 
conventional UV-excitable fluorophores not optimized for 45 
efficient 2PA continue to be utilized. Two-photon photo-
physical characterization databases for commonly used fluo-
rophores and bio-indicators have been reported. Many of 
these compounds exhibit relatively low two-photon absorp-
tion cross-sections (1\), on the order of 10 to 100 GM units. 50 
The (1\) parameter is an indicator of the two-photon absorp-
tion efficiency, and only recently has research been reported 
on the design and development of very efficient 2PA dyes on 
the order of >10 GM units. Much of the synthetic efforts 
have focused on preparing new organic dyes for a range of 55 
applications, as molecules specifically engineered for two-
photon excitation may significantly outperform standard 
fluorophores optimized for single photon excitation. How-
ever, the identification and availability of optimized 2PA 
fluorophores specifically tailored for labeling biomolecules 60 
for two-photon fluorescence imaging studies are rare. To 
date, reactive fluorescent dyes exhibiting high 2PA cross-
sections, specifically to covalently modify biomolecules 
have not been reported. Hence, the need to incorporate 
reactive, efficient 2PA fluorophores for covalent attachment 65 
onto biomolecules within the fluorophore design strategy 
seems timely and fulfills an appropriate need which coin-
In the present invention, a preferred reactive fluorophore 
has the structural formula 
SCN 
and a preferred dye adduct has the structural formula: 
H H 
/N~N 
n-Bu II 
s 
N-(\ fj~)_J· 
s 
A BSA model bioconjugate has the structural formula 
H H 
BSA""'NyN 
s 
and a hydrophilic amine-reactive fluorophore has the struc-
tural formula 
HOOC COOR 
SCN ri) 
s 
in the present invention. 
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A more preferred dye adduct of the present invention is 
hydrophilic and has the structural formula 
ROOC COOR 
4 
R3 is independently amino, hydroxy, halogen, C1 -C6 
alkoxy, C1 -C10 alkyl, C1 -C6 haloalkyl, SH, SCH3 , 
-NH(C
1
-C6 alkyl), -N(C1-C6 alkyl)2, -NH(aryl), 
-N(aryl)2, -NHCO(C1-C4 alkyl), -N=C=S, 
-NH(C=S)-O(C
1 
-C6 alkyl), -NH(C=S)-NH(C1 -
C6 alkyl), -NH(C=S)-N(C1 -C6 alkyl)2, -C02H, or 
---C02(C1 -C6 alkyl). 
R R 
/N~N 
n-Bu II 
N-(\ 
fj ~)__/· 
s 
To more fully understand the scope of the above reaction 
products, a preferred two-photon fluorphore labeled protein 
10 or antibody of the present invention is provided below. 
s 
A preferred hydrophilic protein bioconjugate of the 
present invention has the structural formula 
R R 
N N 
Protien .,,.,.,/ y 
s 
ROOC COOR 
15 
A preferred method of multiphon imaging includes the 25 
use of reactive fluorophores upon a fluorene ring system, 
more preferably, the flurophores are functionalized with 
moieties having the properties of covalent attachment onto 
proteins and antibodies. 
It is also preferred that a Ti:sapphire laser be used to 30 
provide for the multiphoton imaging. 
A preferred generic Two-Photon Reactive Probe Structure 
has the formula 
R 1, R 2, X, and Y are all functionality tailored for specific 
applications 
wherein R1 and R2 are selected from the group, such that R1 
and R2, at each occurrence, are independently C1 -C16 alkyl, 
35 
40 
45 
C1 -C10 haloalkyl, -(CH2)1_9 C02H, -(CH2)1_9 C02(C1-C6 
alkyl), -(CH2CH20)1_10H, -(CH2CH20)1_10(C1-C6 
alkyl); -(CH2CH20)1_10(C02C1 -C6 alkyl); -(CH2CH2 50 
0)1_10(C02H); or -(CH2CH20)1_10(C02-N-succinimidyl); 
X is selected from the group: 
-N=C=S, -N=C=O, C02H, -N-succinimidyl, 
-P(=O)(OH)2, -P(=O)(OH)2, -P(=O)(OH)(O- 55 
C
1
-C6 alkyl), -P(=O)Cl2, P(=O)F2, -P(=O)(F) 
(O-C
1
-C6 alkyl), -P(=O)(Cl)(O---C1-C6 alkyl), 
P(=O)Br2, or -P(=O)(Br)(O---C1 -C6 alkyl); 
wherein Y is selected from the group: 
-NH2, -NH(C1 -C6 alkyl), -N(C1 -C6 alkyl), -N(C1 - 60 
c6 alkyl)2, -NH(aryl), -N(aryl)2, -NHCO(C1-C4 
alkyl), 2-thiazolyl substituted with 0-2 R3 ; 2-oxazolyl 
substituted with 0-2 R3 ; 2-benzothiazolyl substituted 
with 0-4 R3 ; 2-styrlbenzothiazolyl; 2-benzoxazolyl 
substituted with 0-4 R3 ; and 2- or 4-pyridyl substituted 65 
with 0-4 R3 , and N-carbazolyl substituted with 0-4 R3 ; 
and 
A preferred two-photon fluorphore labeled protein of the 
present invention has the formula 
R R 
N N Protien~ y y 
s 
wherein R1 and R2 are selected from the group: 
R1 and R2, at each occurrence, are independently C1-C16 
alkyl, C1 -C10 haloalkyl, -(CH2)1_9 C02H, -(CH2)1_9 
C02(C1 -C6 alkyl), 
-(CH2CH20)1_10H, -(CH2CH20)1_10(C1 -C6 alkyl); 
-(CH
2
CH20)1_10(C02C1 -C6 alkyl); -(CH2CH2 
0)1_10(C02H); or -(CH2CH20)1_10(C02-N-succin-
imidyl; 
wherein Y is selected from the group: 
-NH2, -NH(C1 -C6 alkyl), -N(C1 -C6 alkyl)2, -NH 
(aryl), -N(aryl)2, -NHCO(C1 -C4 alkyl), 2-thiazolyl 
substituted with 0-2 R3 ; 2-oxazolyl substituted with 0-2 
R3 ; 2-benzothiazolyl substituted with 0-4 R3 ; 2-styrl-
benzothiazolyl; 2-benzoxazolyl substituted with 0-4 
R3 ; and 2- or 4-pyridyl substituted with 0-4 R3 , and 
N-carbazolyl substituted with 0-4 R3 ; and 
R3 is independently amino, hydroxy, halogen, C1 -C6 
alkoxy, C1 -C10 alkyl, C1 -C6 haloalkyl, SH, SCH3 , 
-NH(C
1
-C6 alkyl), -N(C1-C6 alkyl)2, -NH(aryl), 
-N(aryl)2, -NHCO(C1-C4 alkyl), -N=C=S, 
-NH(C=S)-O(C
1 
-C6 alkyl), -NH(C=S)-NH(C1 -
C6 alkyl), -NH(C=S)-N(C1 -C6 alkyl)2, -C02H, or 
---C02(C1 -C6 alkyl). 
The present invention also includes a preferred two-
photon fluorphore labeled antibody having the formula 
R R 
N N Antibody~ y y 
s 
wherein R1 and R2 are selected from the group: 
R1 and R2, at each occurrence, are independently C1-C16 
alkyl, C1 -C10 haloalkyl, -(CH2)1_9 C02H, -(CH2)1_9 
C02(C1 -C6 alkyl), 
-(CH2CH20)1_10H, -(CH2CH20)1_10(C1 -C6 alkyl); 
-(CH
2
CH20)1_10(C02C1 -C6 alkyl); -(CH2CH2 
0)1_10(C02H); or -(CH2CH20)1_10(C02-N-succin-
imidyl); 
wherein Y is selected from the group: 
US 7,253,287 Bl 
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-NH2 , -NH(C1 -C6 alkyl), -N(C1 -C6 alkyl)2 , -NH 
(aryl), -N(aryl)2 , -NHCO(C1 -C4 alkyl), 2-thiazolyl 
substituted with 0-2 R3 ; 2-oxazolyl substituted with 0-2 
R3 ; 2-benzothiazolyl substituted with 0-4 R3 ; 2-styrl-
benzothiazolyl; 2-benzoxazolyl substituted with 0-4 5 
R3 ; and 2- or 4-pyridyl substituted with 0-4 R3 , and 
N-carbazolyl substituted with 0-4 R3 ; and 
R3 is independently amino, hydroxy, halogen, C1 -C6 
alkoxy, C1 -C10 alkyl, C1 -C6 haloalkyl, SH, SCH3 , 
-NH(C
1
-C6 alkyl), -N(C1 -C6 alkyl)2 , -NH(aryl), 10 
-N(aryl)2 , -NHCO(C1 -C4 alkyl), -N=C=S, 
-NH(C=S)-O(C
1 
-C6 alkyl), -NH(C=S)-NH(C1 -
C6 alkyl), -NH(C=S)-N(C1 -C6 alkyl)2 , -C02H, or 
--C02 (C1 -C6 alkyl). 
Further objects and advantages of this invention will be 15 
apparent from the following detailed description of the 
presently preferred embodiments which are described in the 
following text. 
BRIEF DESCRIPTION OF THE FIGURES 20 
FIG. 1 shows the preparation of a dye adduct and model 
bioconjugate with a reaction 2PA fluorophore. 
FIG. 2 shows the preparation of a model bioconjugate 
with reactive fluorophore 25 
FIG. 3 shows the structure of a hydrophilic amine-
reaction fluorophore (4) for the preparation of a model 
adduct and bioconjugate. 
FIG. 4 shows normalized UV-visible absorbance (1, 2) 
and fluorescence emission (1', 2'; excitation line indicated) 30 
spectra of the reactive fluorophore 1 and the dye adduct 2. 
FIG. Sa shows the two-photon absorption for the dye 
adduct. 
FIG. Sb shows a log-log plot of the dye adduct integrated 
fluorescence. 35 
FIG. 6 shows normalized absorption spectra of the free 
BSA protein and BSA-dye conjugate (1 and 2) and steady-
state fluorescence emission spectrum of the BSA-dye con-
jugate (2'). 
FIG. 7 is an example of an amine reaction two-photon 40 
fluorescent probe of the present invention. 
DETAILED DESCRIPTION OF THE 
INVENTION 
Before explaining the disclosed embodiment of the 
present invention in detail it is to be understood that the 
invention is not limited in its application to the details of the 
particular arrangement shown since the invention is capable 
of other embodiments. Also, the terminology used herein is 50 
for the purpose of description and not of limitation. 
To better understand this invention as set forth, recall that 
the fluorene ring is a II-conjugated system which allows for 
facile synthetic manipulation, yielding dyes with tailored 
spectral properties. Efforts directed towards preparing reac- 55 
tive fluorescent dyes have been initiated with the synthesis 
of an amine-reactive dye for labeling, e.g., lysine residues on 
proteins. A model dye-adduct exhibiting high fluorescence 
quantum yield (QY=0.74) was also prepared by reacting an 
amine-reactive dye with n-butyl-amine to test its reactivity 60 
as an amine-reactive fluorescent label and determine its 
spectroscopic properties. Additionally, a model protein bio-
conjugate was prepared with the reactive fluorophore and 
bovine serum albumin. Finally, a hydrophilic derivative of 
an amine-reactive dye was prepared to obtain a more water- 65 
soluble dye. The foregoing will become apparent upon 
reading the following experimental discussion. 
6 
EXPERIMENTAL 
Reference should now be made to FIG. 1. The synthesis 
of an amine reactive fluorescent dye (1) was prepared as a 
biological labeling probe (Scheme 1). Intermediate com-
pounds A-F have been described previously in the literature. 
Preparation of reactive probe 1, from aminofluorene F, was 
performed quantitatively, following the literature protocol. 
The procedure for preparation of reactive probe 1 is shown 
in FIG. 1. Compound (1) was prepared as an amine-reactive 
fluorescent dye, containing the isothiocyanate functionality 
that can react with primary amine groups present on protein 
molecules. A model dye-adduct (2) was also prepared by 
reacting (1) with n-butyl-amine to test its reactivity as an 
amine-reactive fluorescent label (FIG. 1). Preparation of the 
model adduct allowed for facile single- and two-photon 
spectroscopic characterizations that more closely resembles 
the bioconjugate than that of the reactive fluorophore alone. 
AcOH, 85° C. 
A 
KOH, KI 
BrC10H21, 25' C. 
DMSO 
B 
c 
1. n-BuLi, -75' C., THF 
2. n-Bu3SnCl, -75' C.-r.t. 
D 
The amine-reactive fluorescent dye (1) was used to prepare 
a bioconjugate (3) with bovine serum albumin (BSA) pro-
tein as a model biomolecule (which is shown in FIG. 2). The 
use of BSA, an inexpensive protein that has been extensively 
characterized, is ideal for establishing optimal conditions to 
obtain a model bioconjugate allowing for subsequent spec-
troscopic characterization. 
The amine reactive reagent (isothiocyanate functional 
group) reacts with non-protonated aliphatic amine groups, 
including the N-terminus of proteins and the E-amino groups 
oflysines (pKa,.,10.5). A typical protocol for the conjugation 
was followed in an amine-free buffer with a slightly basic 
pH (pH=9.0). The amine reactive dye (1) was dissolved in 
DMSO, immediately prior to addition into the stirring BSA 
protein solution. The reaction mixture was allowed to stir at 
US 7,253,287 Bl 
7 
room temperature, after which it was passed through a 
Sephadex G-25 gel filtration column pre-swollen with water 
and equilibrated with phosphate buffer saline (PBS, pH 7 .2) 
solution. Small fractions, eluted with the PBS solution were 
collected into sterile plastic tubes, and the UV-visible 
absorption and steady-state fluorescence emission spectra of 
the bioconjugate were obtained. 
8 
the slopes from the measurements confirm the quadratic 
dependence characteristic of fluorescence obtained from 
two-photon absorption. 
FIGS. Sa-Sb show the two-photon cross section of the dye 
adduct in FIG. Sa, and the log-log plot of its integrated 
fluorescence as a function of pump power variation at two 
different fs excitation wavelengths in FIG. Sb. 
Two different molar ratios of the reactive dye to protein 
were performed to assess the reactivity of the dye for its 10 
degree of labeling (DOL) (Table 1). The degree of labeling 
was estimated using average values from standard equations 
obtained from reference 2S. 
The normalized absorption and steady-state fluorescence 
emission spectra of the BSA-dye bioconjugate (3) in PBS 
buffer (pH 7.2) is shown in FIG. 6. For reference, the 
absorption spectrum of the free BSA protein in PBS solution 
is also shown. The BSA-dye conjugate displays absorption 
peaks corresponding to that of the BSA protein in the shorter 
BSA 
1.53E-8 
mol 
1.53E-8 
mol 
1.53E-8 
mol 
TABLE 1 
Variable degree of labeling obtained by changing the 
molar ratios of the reactive dye to BSA. 
DOL 
Reactive Dye:Protein Reaction (mol dye:mol 
fluorophore mol ratio time protein) 
1.53E-7 10:1 1 h 3.4 
mol 
7.7E-8 5:1 1 h 2.4 
mol 
7.7E-8 5:1 2h 2.2 
mol 
RESULTS AND DISCUSSION OF THE 
INVENTION 
The normalized UV-visible absorption and steady-state 
fluorescence emission spectra of the free reactive fluoro-
phore (1) and the dye adduct (2) in DMSO are shown in FIG. 
4. The free reactive fluorophore exhibits two absorption 
maxima at approximately 357 and approximately 375 nm, 
along with two emission maxima at approximately 384 and 
approximately 404 nm. The dye adduct instead exhibits a 
single absorption maximum at approximately 363 nm with 
an emission maximum at approximately 403 nm, and is well 
resolved from that of its absorption spectrum, with minimal 
spectral overlap. The fluorescence quantum yield (Rhad-
amine 6G in ethanol as a standard) of the reactive fluoro-
phore in DMSO was approximately 0.02, while that of the 
dye adduct in DMSO increased significantly to approxi-
mately 0.74, indicating the fluorescence of the reactive dye 
should be restored upon conjugation to a biomolecule. 
15 wavelength range (llmax =280 nm), as well as that of the 
fluorescent dye in the longer absorption range 
(67 maxuma =360 nm and 380 nm). The fluorescence emission 
of the bioconjugate is broad and exhibits an appreciable 
Stoke's shift. An appreciable bathochromic shift in the 
20 fluorescence emission was observed in the BSA-dye conju-
gate relative to that of the free reactive fluorophore, and with 
a similar broadening observed in the absorption profile, the 
fluorescence emission was also broader than that of the free 
25 
fluorophore. The observed Stoke's shift in the free dye was 
about 45 nm, while that of the BSA-dye conjugate was much 
greater (Stoke's shift=73 nm upon llex=360 nm, and 53 nm 
upon /lex =380 nm). The fluorescence emission profile of the 
BSA-dye conjugate upon excitation at /lex =360 nm and 
30 /lex =380 nm yielded similar fluorescence intensities. 
The spectroscopic profiles of the BSA-dye conjugate 
validate the use of the reactive dye (1) to form bioconjugates 
with protein biomolecules for fluorescence imaging appli-
cations. However, attempts to conjugate the dye onto an 
35 anti-BSA antibody (Molecular Probes) were unsuccessful. 
The two hydrophobic alkyl chains on the fluorene ring may 
have interfered with efficient conjugation onto the higher 
molecular weight of the antibody (-150 kDa) relative to that 
of the smaller protein (-65 kDa ). Hence, a more hydrophilic 
40 derivative of an amine-reactive dye was prepared (com-
pound 4 of FIG. 3). Substitution of the alkyl groups on the 
fluorene ring with carboxylates should enhance the water 
solubility of the reactive de, and is expected to improve its 
45 conjugation to a wider range of biomolecules in aqueous 
media. The FT-IR spectrum of the hydrophilic reactive dye 
(4) displayed a strong NCS stretch at 2118 cm-1, indicating 
the presence of the amine-reactive functionality. Efforts to 
prepare appropriate adducts and bioconjugates with the 
50 hydrophilic dye (4) are currently underway. The two-photon absorption cross sections (from two-
photon fluorescence measurements) for the dye adduct in 
DMSO was obtained under femtosecond (fs) near IR irra-
diation (FIG. Sa). The linear, single photon absorption 
spectrum is shown as the line profile, while the two-photon 
absorption cross sections were measured at wavelengths that 55 
were twice that of the linear absorption, and are shown as the 
data points. The y-axis is shown as two near-IR photons used 
A new series of reactive fluorophores have been prepared 
to covalently label biomolocules for multiphoton imaging. 
These fluorophores are based upon the fluorene ring system 
and exhibit high fluorescence quantum yields upon biocon-
jugation (-0.7). They have been functionalized with moi-
eties to act, e.g., as efficient amine-reactive fluorescent 
probes for the covalent attachment onto, e.g., proteins and 
antibodies. A bovine serum albumin (BSA) conjugate with 
a new reactive probe has been demonstrated. Additionally, a 
hydrophilic reactive fluorophore has been prepared, 
expected to be more efficient for labeling biomaterials in 
aqueous media. These efficient two-photon absorbing reac-
tive dyes are expected to be versatile probes for multiphoton 
bio-imaging applications. 
to obtain the cross section converted to an equivalent single 
photon wavelength. The two-photon absorption cross sec-
tion at the energy of the linear absorption maximum near 60 
370 nm is approximately 25 GM units. Interestingly, while 
the linear absorption spectrum for the compound does not 
display any significant absorption at the shorter wave-
lengths, the value of the two-photon absorption cross section 
increases. To ensure the dye adduct undergoes 2PA, a 65 
log-log plot of the fs pump power to that of the integrated 
fluorescence was constructed. As can be seen from FIG. Sb, 
In summary, there is disclosed numerous structures and 
the preparation provided by the teachings of this invention: 
the dye adduct 
US 7,253,287 Bl 
9 
SCN 
Reactive Fluorophore 
H H 
r-=1) 
s 
n-BuNH2 
r.t. 
10 
10 
-continued 
C10H21 C10H21 
H H 
BSA""'NyN 
s 
BSA Model Bioconjugate 
A hydrophilic amine-reactive fluorophore having the struc-
tural formula 
_......N'-i<N 
n-Bu II 
rD 
s 15 
s 
2 
Dye Adduct (Model Compound) 
The dye adducts that are hydrophilic and have the structural 
formulae 
HOOC 
H H 
,..N"y"N 
COOR 
4 
HOOC COOR 
20 
SCN 
25 
Hydrophilic Reactive Dye 
n-Bu II rj) 
s 30 Generic Two-Photon Reactive Probe Structure 
HOOC 
SCN 
s 
COOR 
4 
Hydrophilic Model Adduct 
N~ 
'I_)_/ 
s 
Hydrophilic Reactive Dye 
Hydrophilic Bioconjugate 
a BSA model bioconjugate having the structural formula 
BSA + 
Model 
Protein 
Reactive Fluorophore 
-r.t. 
35 
40 
45 
55 
x 
R1, R2 , X, and Y are all functionality tailored for specific 
applications 
wherein R1 and R2 are selected from the group: 
R1 and R2 , at each occurrence, are independently C1 -C16 
alkyl, C1 -C10 haloalkyl, -(CH2 ) 1 _9 C02H, -(CH2 ) 1 _9 
C02 (C1 -C6 alkyl), -(CH2CH2 0)1 _10H, -(CH2 CH2 
0)1 _10(C1 -C6 alkyl); -(CH2CH2 0)1 _10(C02 C1 -C6 
alkyl); -CH2CH2 0)1 _10(C02 H); or-(CH2 CH20)1_10 
(C02-N-succinimidyl); 
wherein X is selected from the group: 
-N=C=S, -N=C=O, C02H, -N-succinimidyl, 
-P(=O)(OH)2 , -P(=O)(OH)(O---C1 -C6 alkyl), 
-P(=O)Cl2 , P(=O)F2 , -P(=O)(F)(O-C1-C6 
alkyl), -P(=O)(Cl)(O---C1-C6 alkyl), P(=O)Br2 , or 
-P(=O)(Br)(O-C1-C6 alkyl); 
wherein Y is selected from the group: 
60 -NH2 , -NH(C1 -C6 alkyl), -N(C1 -C6 alkyl), -N(C1 -
C6 alkyl)2 , -NH(aryl), -N(aryl)2 , -NHCO(C1-C4 
alkyl), 2-thiazolyl substituted with 0-2 R3 ; 2-oxazolyl 
substituted with 0-2 R3 ; 2-benzothiazolyl substituted 
with 0-4 R3 ; 2-styrlbenzothiazolyl; 2-benzoxazolyl 
65 substituted with 0-4 R3 ; and 2- or 4-pyridyl substituted 
with 0-4 R3 , and N-carbazolyl substituted with 0-4 R3 ; 
and 
US 7,253,287 Bl 
11 
R3 is independently amino, hydroxy, halogen, C1 -C6 
alkoxy, C1 -C10 alkyl, C1 -C6 haloalkyl, SH, SCH3 , 
-NH(C
1
-C6 alkyl), -N(C1 -C6 alkyl)2 , -NH(aryl), 
-N(aryl)2 , -NHCO(C1 -C4 alkyl), -N=C=S, 
-NH(C=S)-O(C
1 
-C6 alkyl), -NH(C=S)-NH(C1 - 5 
C6 alkyl), -NH(C=S)-N(C1 -C6 alkyl)2 , -C02H, or 
--C02 (C1 -C6 alkyl). 
FIG. 7 and the example below are further illustrative of 
the scope of this invention as an amine reactive two-photon 
fluorescent probe. 10 
Example of an Amine Reactive Two-Photon 
Fluorescent Probe 
S::::::,C 
""°N vV 
s 
reactive probe 
15 
20 
12 
3. A BSA model bioconjugate of the structural formula 
H H 
BSAVVV>NYN 
s 
N-{\ 
r ~)_J· 
s 
4. A hydrophilic amine-reactive fluorophore of the struc-
tural formula 
HOOC COOR 
SCN rj) 
s 
Protein or Antibody 5. An Adduct according to claim 2 which is hydrophilic 
25 and of the structural formula 
H 
S.:::::. /N 
c 
I 
NH 
~ 
v-JJ 
s 
Two-Photon Fluorophore-Labeled Protein or 
Antibody 
While the invention has been described, disclosed, illus-
trated and shown in various terms of certain embodiments or 
modifications which it has presumed in practice, the scope 
30 
35 
40 
of the invention is not intended to be, nor should it be 
deemed to be, limited thereby and such other modifications 45 
or embodiments as may be suggested by the teachings herein 
are particularly reserved especially as they fall within the 
breadth and scope of the claims here appended. 
HOOC COOR 
H H 
/N"-i<N 
n-Bu II 
s 
6. A hydrophilic protein bioconjugate of the structural 
formula 
H H 
N N 
Protien ,.,,,.,/ y 
s 
HOOC COOR 
N-(\ r;~J_J· 
s 
7. A Generic Two-Photon Reactive Probe Structure of the We claim: 
1. A reactive fluorophore of the structural formula 
50 formula 
SCN 
N~ ~ ~J-J· 
s 
2. A dye adduct of the structural formula 
H H 
/N"-i<N 
n-Bu II 
s 
55 
60 
65 
x 
wherein R1, R2 , X, and Y are all functionality tailored for 
specific applications; and 
R1 and R2 , at each occurrence, are independently C1 -C16 
alkyl, C1 -C10 haloalkyl, -(CH2 ) 1 _9 C02H, -(CH2 ) 1 _9 
C02 (C1 -C6 alkyl), 
-(CH2 CH20)1_10H, -(CH2CH2 0)1 _10(C1 -C6 alkyl); 
-(CH
2
CH2 0)1 _10(C02C1 -C6 alkyl); -(CH2 CH2 
0)1 _10(C02 H); or -(CH2 CH20)1_10(C02-N-succin-
imidyl; and 
US 7,253,287 Bl 
13 
X is selected from the group: 
-N=C=S, -N=C=O, C02 H, -N-succinimidyl, 
-P(=O)(OH)2 , -P(=O)(OH)(O---C1 -C6 alkyl), 
-P(=O)Cl2 , P(=O)F2 , -P(=O)(F)(O-C1-C6 
alkyl), -P(=O)(Cl)(O---C1 -C6 alkyl), P(=O)Br2 , or 5 
-P(=O)(Br)(O-C1-C6 alkyl); and 
Y is selected from the group: 
-NH2 , -NH(C1 -C6 alkyl), -N(C1 -C6 alkyl)2 , -NH 
(aryl), -N(aryl)2 , -NHCO(C1 -C4 alkyl), 2-thiazolyl 
substituted with 0-2 R3 ; 2-oxazolyl substituted with 0-2 10 
R3 ; 2-benzothiazolyl substituted with 0-4 R3 ; 2-styrl-
benzothiazolyl; 2-benzoxazolyl substituted with 0-4 
R3 ; and 2- or 4-pyridyl substituted with 0-4 R3 , and 
N-carbazolyl substituted with 0-4 R3 ; and 
R3 is independently amino, hydroxy, halogen, C1 -C6 15 
alkoxy, C1 -C10 alkyl, C1 -C6 haloalkyl, SH, SCH3 , 
-NH(C
1
-C6 alkyl), -N(C1 -C6 alkyl)2 , -NH(aryl), 
-N(aryl)2 , -NHCO(C1 -C4 alkyl), -N=C=S, 
-NH(C=S)-O(C
1 
-C6 alkyl), -NH(C=S)-NH(C1 -
C6 alkyl), -NH(C=S)-N(C1 -C6 alkyl)2 , -C02H, or 20 
---C02 (C1 -C6 alkyl). 
8. A two-photon fluorphore labeled protein of the formula 
25 
H H 
N N 
14 
R3 ; and 2- or 4-pyridyl substituted with 0-4 R3 , and 
N-carbazolyl substituted with 0-4 R3 ; and 
R3 is independently amino, hydroxy, halogen, C1 -C6 
alkoxy, C1 -C10 alkyl, C1 -C6 haloalkyl, SH, SCH3 , 
-NH(C
1
-C6 alkyl), -N(C1 -C6 alkyl)2 , -NH(aryl), 
-N(aryl)2 , -NHCO(C1-C4 alkyl), -N=C=S, 
-NH(C=S)-O(C
1 
-C6 alkyl), -NH(C=S)-NH(C1 -
C6 alkyl), -NH(C=S)-N(C1 -C6 alkyl)2 , -C02H, or 
---C02 (C1 -C6 alkyl). 
9. A two-photon fluorphore labeled antibody of the for-
mula 
H H 
N N 
Antibody...,..,./ y Y, 
s 
wherein R1 and R2 are selected from the group wherein: 
R1 and R2 , at each occurrence, are independently C1 -C16 
alkyl, C1 -C10 haloalkyl, -(CH2 ) 1 _9 C02H, -(CH2 ) 1 _9 
C02 (C1 -C6 alkyl), 
-(CH2 CH20)1_10H, -(CH2CH2 0)1 _10(C1 -C6 alkyl); 
-(CH
2
CH2 0)1 _10(C02C1 -C6 alkyl); -(CH2 CH2 
0)1 _10(C02 H); or -(CH2 CH20)1_10(C02-N-succin-
imidyl; and Protien ...,..,./ y 
s 30 Y is selected from the group: 
wherein R1 and R2 are selected from the group wherein: 
R1 and R2 , at each occurrence, are independently C1 -C16 
alkyl, C1 -C10 haloalkyl, -(CH2 ) 1 _9C02 H, -(CH2 ) 1 _9 35 
C02 (C1 -C6 alkyl), 
-(CH2 CH20)1_10H, -(CH2 CH20)1_10(C1 -C6 alkyl); 
-(CH
2
CH2 0)1 _10(C02C1 -C6 alkyl); -(CH2 CH2 
0)1 _10(C02 H); or -(CH2 CH2 0)1 _10(C02-N-succin-
imidyl; and 
Y is selected from the group: 
40 
-NH2 , -NH(C1 -C6 alkyl), -N(C1 -C6 alkyl)2 , -NH 
(aryl), -N(aryl)2 , -NHCO(C1 -C4 alkyl), 2-thiazolyl 
substituted with 0-2 R3 ; 2-oxazolyl substituted with 0-2 
R3 ; 2-benzothiazolyl substituted with 0-4 R3 ; 2-styrl- 45 
benzothiazolyl; 2-benzoxazolyl substituted with 0-4 
-NH2 , -NH(C1 -C6 alkyl), -N(C1 -C6 alkyl)2 , -NH 
(aryl), -N(aryl)2 , -NHCO(C1 -C4 alkyl), 2-thiazolyl 
substituted with 0-2 R3 ; 2-oxazolyl substituted with 0-2 
R3 ; 2-benzothiazolyl substituted with 0-4 R3 ; 2-styrl-
benzothiazolyl; 2-benzoxazolyl substituted with 0-4 
R3 ; and 2- or 4-pyridyl substituted with 0-4 R3 , and 
N-carbazolyl substituted with 0-4 R3 ; and 
R3 is independently amino, hydroxy, halogen, C1 -C6 
alkoxy, C1 -C10 alkyl, C1 -C6 haloalkyl, SH, SCH3 , 
-NH(C1-C6 alkyl), -N(C1 -C6 alkyl)2 , -NH(aryl), 
-N(aryl)2 , -NHCO(C1-C4 alkyl), -N=C=S, 
-NH(C=S)-O(C
1 
-C6 alkyl), -NH(C=S)-NH(C1 -
C6 alkyl), -NH(C=S)-N(C1 -C6 alkyl)2 , -C02H, or 
---C02 (C1 -C6 alkyl). 
* * * * * 
